254 related articles for article (PubMed ID: 2903954)
1. Anti-retroviral effects of interferon-alpha in AIDS-associated Kaposi's sarcoma.
Lane HC; Kovacs JA; Feinberg J; Herpin B; Davey V; Walker R; Deyton L; Metcalf JA; Baseler M; Salzman N
Lancet; 1988 Nov; 2(8622):1218-22. PubMed ID: 2903954
[TBL] [Abstract][Full Text] [Related]
2. Clinical and virological effects of high-dose recombinant interferon-alpha in disseminated AIDS-related Kaposi's sarcoma.
de Wit R; Schattenkerk JK; Boucher CA; Bakker PJ; Veenhof KH; Danner SA
Lancet; 1988 Nov; 2(8622):1214-7. PubMed ID: 2903953
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, safety, and tolerance of low-dose, long-term interferon-alpha 2b and zidovudine in early-stage AIDS-associated Kaposi's sarcoma.
Mauss S; Jablonowski H
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Oct; 10(2):157-62. PubMed ID: 7552479
[TBL] [Abstract][Full Text] [Related]
4. Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS).
Krown SE; Gold JW; Niedzwiecki D; Bundow D; Flomenberg N; Gansbacher B; Brew BJ
Ann Intern Med; 1990 Jun; 112(11):812-21. PubMed ID: 1971504
[TBL] [Abstract][Full Text] [Related]
5. A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma.
Fischl MA; Uttamchandani RB; Resnick L; Agarwal R; Fletcher MA; Patrone-Reese J; Dearmas L; Chidekel J; McCann M; Myers M
J Acquir Immune Defic Syndr (1988); 1991; 4(1):1-10. PubMed ID: 1670585
[TBL] [Abstract][Full Text] [Related]
6. Interferon administered intralesionally in skin and oral cavity lesions in heterosexual drug addicted patients with AIDS-related Kaposi's sarcoma.
Sulis E; Floris C; Sulis ML; Zurrida S; Piro S; Pintus A; Contu L
Eur J Cancer Clin Oncol; 1989 Apr; 25(4):759-61. PubMed ID: 2714351
[No Abstract] [Full Text] [Related]
7. Low-dose interferon alpha combined with zidovudine in patients with AIDS-associated Kaposi's sarcoma.
Podzamczer D; Bolao F; Clotet B; García P; Casanova A; Pagerols X; Gudiol F
J Intern Med; 1993 Mar; 233(3):247-53. PubMed ID: 8095516
[TBL] [Abstract][Full Text] [Related]
8. Intralesional interferon-alpha and zidovudine in epidemic Kaposi's sarcoma.
Dupuy J; Price M; Lynch G; Bruce S; Schwartz M
J Am Acad Dermatol; 1993 Jun; 28(6):966-72. PubMed ID: 8496462
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy and alpha-interferon in the treatment of Kaposi's sarcoma associated with acquired immune deficiency syndrome.
Shepherd FA; Evans WK; Garvey B; Read SE; Klein M; Fanning MM; Coates R
CMAJ; 1988 Oct; 139(7):635-9. PubMed ID: 2458177
[TBL] [Abstract][Full Text] [Related]
10. Combined treatment with zidovudine and lymphoblast interferon-alpha in patients with HIV-related Kaposi's sarcoma.
Baumann R; Täuber MG; Opravil M; Hirschel B; Kinloch S; Chave JP; Pletscher M; Lüthy R
Klin Wochenschr; 1991 May; 69(8):360-7. PubMed ID: 1909399
[TBL] [Abstract][Full Text] [Related]
11. AIDS-related Kaposi's sarcoma in a heterosexual female.
Ko CB; Walton S; Keczkes K; Greenstone M; Bury HP
Br J Dermatol; 1992 Jan; 126(1):74-6. PubMed ID: 1536765
[No Abstract] [Full Text] [Related]
12. Treatment of epidemic Kaposi's sarcoma with a combination of interferon-alpha 2b and etoposide.
Krigel RL; Slywotzky CM; Lonberg M; Green MD; Andes WA; Kempf R; Gupta S; Grace W; Spiegel RJ; Muggia FM
J Biol Response Mod; 1988 Aug; 7(4):359-64. PubMed ID: 3049944
[TBL] [Abstract][Full Text] [Related]
13. Interferon alpha in the treatment of AIDS-related Kaposi's sarcoma.
Mitsuyasu RT
Br J Haematol; 1991 Oct; 79 Suppl 1():69-73. PubMed ID: 1931714
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-4 in the treatment of AIDS-related Kaposi's sarcoma.
Tulpule A; Joshi B; DeGuzman N; Espina BM; Mocharnuk R; Prakash O; Templeton D; Levine AM; Gill PS
Ann Oncol; 1997 Jan; 8(1):79-83. PubMed ID: 9093711
[TBL] [Abstract][Full Text] [Related]
15. Combined zidovudine and interferon-alpha treatment in patients with AIDS-associated Kaposi's sarcoma.
de Wit R; Danner SA; Bakker PJ; Lange JM; Eeftinck Schattenkerk JK; Veenhof CH
J Intern Med; 1991 Jan; 229(1):35-40. PubMed ID: 1995761
[TBL] [Abstract][Full Text] [Related]
16. AIDS-associated Kaposi's sarcoma and the mechanisms of interferon alpha's activity; a riddle within a puzzle.
de Wit R
J Intern Med; 1992 Apr; 231(4):321-5. PubMed ID: 1588254
[TBL] [Abstract][Full Text] [Related]
17. Low incidence of anti-interferon-alpha antibodies in patients treated with interferon-alpha-2a for AIDS-associated Kaposi's sarcoma.
de Wit R; Bakker PJ; Danner SA; Goudsmit J; Veenhof KH
Int J STD AIDS; 1990 Jul; 1(4):256-8. PubMed ID: 2088534
[TBL] [Abstract][Full Text] [Related]
18. Lymphangioma-like variant of AIDS-associated Kaposi's sarcoma with pronounced edema formation.
Bossuyt L; Van den Oord JJ; Degreef H
Dermatology; 1995; 190(4):324-6. PubMed ID: 7655117
[TBL] [Abstract][Full Text] [Related]
19. Therapy of epidemic Kaposi's sarcoma.
Groopman JE
Semin Hematol; 1986 Jul; 23(3 Suppl 1):14-9. PubMed ID: 3090689
[TBL] [Abstract][Full Text] [Related]
20. Interferon-alpha 2a in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma.
Evans LM; Itri LM; Campion M; Wyler-Plaut R; Krown SE; Groopman JE; Goldsweig H; Volberding PA; West SB; Mitsuyasu RT
J Immunother (1991); 1991 Feb; 10(1):39-50. PubMed ID: 1826454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
